Effect of a gadodiamide contrast agent on the reliability of brain tissue T1 measurements

Magn Reson Imaging. 1999 Feb;17(2):229-35. doi: 10.1016/s0730-725x(98)00094-0.

Abstract

To determine whether brain spin-lattice relaxation time (T1) can routinely be measured after contrast-agent injection, we measured T1 by a precise and accurate inversion-recovery (PAIR) method in five brain tumor patients, before and again after contrast-agent injection. The T1 in at least 20 regions of interest (ROIs) was measured in each patient, avoiding areas of contrast enhancement visible by conventional MR imaging. Contrast-agent injection reduced T1 in 51 regions of interest in white matter by less than 1% (not significant), and in 50 regions of interest in gray matter by less than 2% (p = 0.001). Pixel-by-pixel plots demonstrate that T1 is reduced substantially in extra-parenchymal tissues, but not in brain tissues. Therefore, T1 mapping with the precise and accurate inversion-recovery method can routinely be done after contrast injection. Our results suggest that the precise and accurate inversion-recovery method is not sensitive to the T1 of blood in the presence of an intact blood-brain barrier, although a substantial T1 reduction does occur in the absence of a blood-brain barrier.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Blood-Brain Barrier
  • Brain / pathology*
  • Brain Neoplasms / pathology*
  • Child
  • Contrast Media
  • Female
  • Gadolinium DTPA*
  • Humans
  • Injections, Intravenous
  • Magnetic Resonance Imaging / methods*
  • Male

Substances

  • Contrast Media
  • gadodiamide
  • Gadolinium DTPA